Pancreatic endocrine cells expand rapidly during embryogenesis by neogenesis and proliferation, but during adulthood, islet cells have a very slow turnover. Disruption of murine retinoblastoma tumor suppressor protein (Rb) in mature pancreatic β-cells has a limited effect on cell proliferation. Here we show that deletion of Rb during embryogenesis in islet progenitors leads to an increase in the neurogenin 3-expressing precursor cell population, which persists in the postnatal period and is associated with increased β-cell mass in adults. In contrast, Rb-deficient islet precursors, through repression of the cell fate factor aristaless related homeobox, result in decreased α-cell mass. The opposing effect on survival of Rb-deficient α-and β-cells was a result of opposing effects on p53 in these cell types. As a consequence, loss of Rb in islet precursors led to a reduced α-to β-cell ratio, leading to improved glucose homeostasis and protection against diabetes.
Pancreatic endocrine cells expand rapidly during embryogenesis by neogenesis and proliferation, but during adulthood, islet cells have a very slow turnover. Disruption of murine retinoblastoma tumor suppressor protein (Rb) in mature pancreatic β-cells has a limited effect on cell proliferation. Here we show that deletion of Rb during embryogenesis in islet progenitors leads to an increase in the neurogenin 3-expressing precursor cell population, which persists in the postnatal period and is associated with increased β-cell mass in adults. In contrast, Rb-deficient islet precursors, through repression of the cell fate factor aristaless related homeobox, result in decreased α-cell mass. The opposing effect on survival of Rb-deficient α-and β-cells was a result of opposing effects on p53 in these cell types. As a consequence, loss of Rb in islet precursors led to a reduced α-to β-cell ratio, leading to improved glucose homeostasis and protection against diabetes.
diabetes mellitus | insulin | glucagon | cell cycle | E2f P ancreatic α-and β-cells control glucose homeostasis through glucagon and insulin, which have opposing effects (1) . The pancreatic islet cell mass is achieved through a rapid surge of neogenesis and proliferation that occurs during the perinatal period (2) . However, this plasticity declines significantly in the postnatal period (3), resulting in a limited ability of islets to regenerate in adulthood (4) . However, molecular mechanisms that govern both neogenesis and proliferation in islet cells remain elusive. Better understanding of these processes may allow for the development of therapeutic strategies to treat diabetes.
During embryogenesis, the pancreas develops from foregut endoderm progenitors, which start expressing pancreatic and duodenal homeobox 1 (Pdx1) at embryonic day 8.5 (E8.5) (5) . Islet endocrine cells derive from neurogenin 3 (Ngn3)-expressing precursors located in the pancreatic epithelium at E8.75 (6) . Once islet precursors adopt a cell identity by producing α-or β-cell hormones, these cells become postmitotic, after which only a limited number (<10%) of differentiated cells can reenter the cell cycle and contribute to prenatal islet expansion (7, 8) . Neogenesis, a proliferation process of undifferentiated precursors, is the main mode through which rapid islet expansion is achieved in the late phase of fetal development (2) . However, neogenesis declines rapidly in the postnatal period, and Ngn3-expressing islet precursor cells become virtually absent by age 1 wk in mice (9, 10) . Thereafter, the majority of islets are maintained in a noncycling state without the ability to readily self-replicate.
The retinoblastoma tumor suppressor protein (Rb) functions as a major gatekeeper of cell cycle progression from G1 to S phase and is required for maintaining cells in the noncycling, quiescent stage (11) . Rb inhibits cell cycle progression by binding to transcription factors such as E2f transcription factor 1 (E2f1) and inhibiting their transactivation (11) . Rb phosphorylation leads to its dissociation from E2f and the transcription of E2f-regulated genes that are required for S phase entry (12) . In addition to cell cycle regulation, Rb controls multiple other cellular processes, including differentiation (13), senescence (14) , and apoptosis (15) , in a highly cell-specific and context-dependent manner (16, 17) . Although Rb is critical in regulating cell cycle entry in proliferating cells, its role in postmitotic cells is more limited. For example, Rb deficiency in proliferating myoblasts induces increased proliferation and apoptosis (18) , whereas Rb deficiency in postmitotic muscle fibers does not lead to any defects (19) . Rb has also been shown to control cell lineage commitment in several cell types, including mesenchymal stem cells (20) and preadipocytes (21) . In the pancreas, Rb has been shown to play a minor role in well-differentiated β-cells, as evidenced by mice with rat insulin promoter-Cre-driven Rb deletion (22) . However, E2f1 is required for normal pancreatic islet function and homeostasis (23, 24) . E2f1 directly regulates insulin secretion through modulating inward rectifier potassium channel Kir6.2 expression (25) . Although these results suggest a role for Rb in islet development and function, the effect of Rb disruption in proliferating islet precursors is unknown.
To address this issue, we deleted Rb in Pdx1-expressing pancreatic progenitors. Remarkably, as opposed to the minor effect of Rb deletion in postmitotic β-cells, disruption of Rb in pancreatic progenitors had a profound effect on both pancreatic α-and β-cell fates. Rb deficiency led to increased Ngn3 and neurogenic differentiation 1 (NeuroD1) expression in islets, which represent multipotent endocrine islet cells. These Rb-deficient precursors showed enhanced β-cell differentiation during embryogenesis. Furthermore, Ngn3 expression persisted postnatally in Rb-deficient islets, which were associated with increased β-cell mass. In contrast, Rb-deficient islet precursors failed to differentiate into mature α-cells because of the repression of an α-cell developmental gene, aristaless related homeobox (Arx), resulting in a reduced α-cell mass. These opposing effects on α-and β-cell differentiation and survival resulting from Rb loss led to improved glucose homeostasis and protection against diabetes.
Results

Rb Deficiency in Islet Precursors Promotes β-Cell Fate Through
Differentiation and Neogenesis. To investigate the physiologic role of Rb in regulating islet cell fate, we deleted Rb in Pdx1-expressing pancreatic progenitor cells, using the Cre-loxP recombination system (26), yielding Pdx1-Cre + Rb fl/fl mice, denoted herein as pancreas-specific Rb knockout (p-RbKO) mice (Fig.  S1A ). To elucidate whether Rb is involved in regulating islet cell differentiation, we first examined the islet cell population in fetal pancreas at E16.5, when multipotent islet precursors are developing into single-hormone-expressing differentiated endocrine cells.
Intriguingly, we observed an increase in Ngn3 expression in islets of p-RbKO pancreata at E16.5 compared with littermate controls ( Fig. 1A and Fig. S1B ). The increase in this key determinant of endocrine lineage was observed along with another critical downstream islet differentiation factor, NeuroD1 (Fig. 1A and Fig. S1B ). To examine development into β-cell lineage, we next assessed for β-cell differentiation markers, NK6 homeobox 1 (Nkx6.1) and musculoaponeurotic fibrosarcoma oncogene family proteins A (MafA), which were also increased ( Fig. 1A and Fig.  S1B ). All of these developmental markers also had a high proportion of cells that coexpressed insulin (Fig. 1A and Fig. S1B ), which together indicated that Rb deficiency in pancreatic progenitors led to an increase in the number of endocrine precursors and enhanced differentiation into β-cells.
Expression of Ngn3 persisted postnatally up to 4 wk of age in p-RbKO mice compared with littermate controls (Fig. 1 B and C and Table S1 ). Consistent with this gene expression profile, Ngn3-expressing islet cells were present in 4-8-wk-old p-RbKO mice, and these cells coexpressed insulin ( Fig. 1D and Fig. S1C ). These results suggest that Rb in islet precursors plays a critical role in regulating Ngn3 expression, and the preserved Ngn3 + cell population is capable of differentiating into mature β-cells in the absence of Rb.
Ngn3 can activate downstream homeodomain-containing transcription factor, paired box 4 (Pax4) (27) , which can act as a repressor of Arx; together, they mediate proper endocrine islet cell specification (28) . Consistent with the findings in fetal p-RbKO pancreas, the increased Ngn3 level was associated with a significant induction of Pax4 expression in neonatal p-RbKO pancreas (Fig.  1E) . In addition, expression of Pdx1 and MafA, which are also required for β-cell specification, were significantly elevated (Fig. 1E ). In keeping with these increases in β-cell neogenesis and differentiation markers, p-RbKO pancreata exhibited an increase in single or small clusters of insulin-expressing cells in close proximity to pancreatic ducts (Fig. S1D) , where endocrine progenitor cells are known to arise (2) , and coexpressed the ductal maker cytokeratin 19 ( Fig. 1F and Fig. S1E ). Furthermore, we observed an increase in the number of small islets (Fig. S1F) . Together, these data demonstrate an increase in Ngn3
+ precursor cell population leading to increased β-cell differentiation during embryogenesis and increased postnatal β-cell neogenesis in p-RbKO mice.
Rb Ablation Disrupts α-Cell Development and Converts α-Cells to β-Cells. As Pax4 specifically favors commitment to β-cell lineage during pancreas development, we asked whether the increased Pax4 in fetal Rb-deficient islets might direct α-cells to transdifferentiate into β-cells. To assess for this possibility, we costained glucagon with the β-cell differentiation marker MafA on fetal pancreata. Remarkably, ∼40% of Glu + cells coexpressed MafA in p-RbKO pancreata at E16.5, showing an adoption of β-cell identity in α-cells along with an increase in insulin and Nkx6.1 coexpression (Figs. 2A and S2A). These results suggest conversion of α-cells to β-cells in p-RbKO embryos, which may at least in part have contributed to the decreased α-cell mass observed in neonatal p-RbKO mice (Figs. 2B and S2B). To further investigate whether Rb had a direct role in regulating α-cell differentiation, we searched for E2f-binding sites in α-cell developmental genes. Interestingly, we found a conserved E2f1 binding site in exon 2 of the human, mouse, and rat Arx gene, which encodes a transcription factor that promotes α-cell fate (Fig. S2C ). To determine whether Rb and E2f regulate Arx, we knocked down Rb by small interfering (si)RNA in a pancreatic α-cell line, simian virus 40 T-antigen induced glucagonoma cells (α-TC), and performed a chromatin immunoprecipitation assay to assess E2f1 recruitment to the Arx promoter. In the absence of Rb, there was an increase in E2f1 binding to exon 2 of Arx ( Fig.  2C and Fig. S2D ), which was associated with a decrease in Arx gene expression (Fig. S2E ). In contrast, E2f1 or combined Rb and E2f1 knockdown restored Arx levels in α-cells (Fig. S2F ), suggesting that repression of Arx was E2f1-dependent. Consistent with these in vitro findings, gene expression levels of Arx were significantly lower in neonatal pancreata and adult islets of pRbKO mice compared with control littermates (Fig. 2D ). In line with these findings, we observed a significant reduction in serum glucagon levels in fasting p-RbKO mice (Fig. 2E) . Thus, Rb loss affects α-cell fate through Arx gene repression, leading to disrupted α-cell specification and transdifferentiation to β-cells.
Rb Deletion in Islet Precursors Leads to Increased β-Cell Mass and
Function. In accordance with the effects of Rb on α-and β-cell differentiation, postnatal day 1 (P1) p-RbKO mice exhibited a significant decrease in α-to β-cell cell mass ratio (Fig. 3A) , along with an increase in β-cell mass (Fig. 3B ). These effects in α-and β-cells persisted up to 22 wk of age ( Fig. 3 A and B) , whereas pRbKO mice exhibited body and pancreas weights similar to those of their control littermates ( Fig. S3 A-D) . Because differentiation of δ-cell and pancreatic polypeptide (PP) cells are also determined by Arx and Pax4, we next measured δ-cell and PP cell mass, as well as e-cell mass, in p-RbKO mice. Consistent with a previous report (29) in which ectopic expression of Pax4 resulted in a low Arx/Pax4 ratio and conversion of Glu + cells into Ins + cells without changing δ-and PP-cell mass, we observed similar δ-cell, PP cell, and e-cell mass in p-RbKO mice compared with controls ( Fig. S3 E and F) .
Similar to the newborns, adult p-RbKO mice exhibited an increased β-cell mass (Fig. 3B ) along with increased postnatal Ngn3 expression. Interestingly, Ngn3 expression has recently been found in dedifferentiated β-cells under diabetic conditions (30) or after extreme islet loss (29, 31) . We next asked whether β-cells in p-RbKO mice underwent normal differentiation, particularly in the presence of persistent postnatal Ngn3 expression. We measured glucose transporter 2 (Glut2), a marker for glucosensing and differentiated β-cells. In contrast to dedifferentiation that occurs in proliferating β-cells (30), Glut2 was expressed on β-cell membrane (Fig. S3G ) in p-RbKO islets. Furthermore, some Ngn3-expressing cells coexpressed Glut2 (Fig. 3C) , and these two proteins remained persistently elevated (Fig. 3D) , which suggests that the increased β-cell mass in p-RbKO mice is also functional. Consistent with this idea, glucose-stimulated insulin secretion was modestly increased in p-RbKO mice in vivo (Fig.  3E ) and in vitro in isolated Rb-deficient islets (Fig. S3H) , which may at least in part be contributed by the increased β-cell mass. Increased nonfasting insulin levels ( Fig. 3F) and Insulin gene expression in Rb-deficient islets (Fig. 3G ) also support the idea that these β-cells are functional and are not dedifferentiated. Known determinants of β-cell function including Pdx1, MafA, and Kir6.2, a key component of the K ATP channel required for insulin secretion, were also increased in Rb-deficient islets (Fig. 3G) . Together, these data suggest that Rb controls islet cell fate determination, and its loss leads to increased β-cell lineage differentiation, mass, and function.
the direct roles of Rb in respective cell lines in vitro, which would eliminate any confounding secondary paracrine or autocrine effects that may occur in vivo. Interestingly, we observed that Rb was differentially expressed in pancreatic α-and β-cells under basal conditions, with higher levels in α-TC cells compared with a β-cell line, insulinoma cells (INS-1) (Fig. 4A and Fig. S4 A  and B) . In both α-and β-cell lines, knockdown of Rb by siRNA led to induction of E2f1 expression (Fig. 4B and Fig. S4C) . Interestingly, however, this resulted in opposing effects on tumor suppressor p53. In α-cells, E2f1 induction led to upregulation (or stabilization) of p53 (Fig. 4B) , which was associated with an increase in apoptosis, as assessed by propidium iodide staining (Fig. S4D) , and an approximately threefold increase in apoptotic subG1 fraction, as determined by DNA content, using flow cytometry (Fig. 4C) . Consistent with these findings, α-cell number decreased after Rb knockdown (Fig. S4E) .
In striking contrast to the induction of p53 in Rb-deficient α-cells, Rb knockdown in the β-cell line, INS-1, led to a decrease in p53 protein expression (Fig. 4B) . Consistent with this, there was an increase in Rb-deficient β-cells in S phase (Fig. 4C) and a higher total cell number (Fig. S4E) . double minute 2 (Mdm2) (32) . Interestingly, knockdown of Rb led to induction of Arf in α-cells and suppression of Arf in β-cells (Fig. S4F) . To assess the direct contribution of E2f1 in these opposing effects, we knocked down E2F1. This abolished the differential effect of Rb knockdown on Arf seen in the two cell types, suggesting that the regulation of Arf by Rb was E2F1-dependent. Interestingly, concomitant knockdown of E2f1 and Rb led to a further decrease in Arf gene expression in α-cells and an increase in β-cells (Fig. S4F) . One possible explanation for these observations is a compensatory effect by E2f3, another E2f family member that is also an E2f1 target gene. E2f3 has been shown to directly repress Arf expression (33) . Together, these results suggest that E2f1 has direct opposing effects on Arf/ p19 expression and p53 stability, leading to differential effects on the survival of α-and β-cells.
p-RbKO Mice Have Increased β-Cell Mass with Improved Glucose
Tolerance. Consistent with the in vitro data, Rb deficiency also led to increased β-cell proliferation and α-cell apoptosis in vivo, as evident from a higher percentage of Ki67-positive Ins + cells (Fig. S5A) and TUNEL-positive Glu + cells in p-RbKO islets (Figs. 5A and S5B). Similar levels of α-cell proliferation (Fig.  S5A ) and β-cell apoptosis (Fig. S5C) were observed in p-RbKO mice and controls. Interestingly, increased α-cell death did not persist in p-RbKO mice with aging (Fig. S5B) , which may explain the remnant, albeit low, α-cell number in p-RbKO mice.
The increased β-cell proliferation was further associated with Mdm2-p53 interaction in Rb-deficient β-cells. Remarkably, coimmunoprecipitation of Mdm2 and p53 showed a reduction in p53 protein levels, suggesting elevated association between the two proteins in p-RbKO islets (Fig. 5B and Fig. S5D ). In addition, p21 and p27 protein expression was decreased with an increase in E2f1, Ccne, and Ccnd1 transcripts and their respective proteins, E2f1, Cyclin E, and D1, in p-RbKO islets compared with controls ( Fig. 5C and Fig. S5 E and F) . These results suggest that Rb-deficient islet cells remain in a proliferative state, likely resulting from increased sensitization to growth signals, as evidenced by reduced expression of Arf/p19, leading to Mdm2 activation and subsequent p53 degradation to further enhance their survival and replication.
To investigate the physiological effects of pancreatic Rb deletion on glucose homeostasis, we measured glucose levels in p-RbKO mice. These mice had lower blood glucose levels (Fig.  S5G ) and significantly improved glucose tolerance compared with control littermates (Fig. 5D) . We attribute this to the increase in pancreatic β-cell mass and function along with a concomitant decrease in α-cell mass rather than changes in insulin sensitivity, as p-RbKO mice exhibited glucose lowering during an insulin tolerance test similar to that of control littermates (Fig. S5H) . To investigate whether the increase in β-to α-cell ratio and β-cell function in Rb-deficient islets had a protective effect against diabetes, we administered multiple low doses of streptozotocin (STZ), which induces diabetes through β-cell toxicity and secondary α-cell expansion (34, 35) . p-RbKO mice were protected from STZ-induced diabetes throughout a 2-mo follow-up period after STZ injection (Fig. 6A) . Similar to the basal state, p-RbKO mice maintained a higher β-cell area (Fig. 6B and Fig. S5I ) and lower α-cell area compared with control mice (Fig. S5J) after STZ injection. This was accompanied by a decrease in TUNELpositive β-cells in p-RbKO mice compared with control littermates (Fig. 6 B and C) and an increase in islet cell proliferation (Fig. 6D) . Together, our data demonstrate that Rb deletion in pancreatic progenitor cells leads to a favorable α-to β-ratio and improved glucose homeostasis under physiological conditions, as well as under conditions that promote diabetes.
Discussion
The adult endocrine pancreas has a very slow turnover (36) , and maintenance of the β-cell mass is mostly achieved by self-replication of preexisting β-cells at a very slow rate (8) . Several studies have attempted to increase endocrine, and particularly β-cell, proliferation through regulation of cell cycle proteins (37, 38) . Specifically, deletion of the cell cycle regulator Rb in differentiated β-cells did not significantly alter β-cell mass (22) . The challenge in defining the role of Rb in different tissues lies in its specificity not only to cell type but also to precise stages in the cellular differentiation. To understand the role of Rb in both α-and β-cells, we deleted Rb, using Pdx1-Cre, in pancreatic precursors in their proliferative phase. Using this mutant model, we demonstrate that deletion of Rb in pancreatic progenitors has dramatic effects on Ngn3-expressing islet precursors, with a shift toward a β-cell specification and increased expression levels of Pax4, Nkx6.1, and MafA. In contrast to its effects on β-cells, Pdx1-Cre-driven Rb loss led to repression of Arx, with conversion of glucagon-expressing α-cells into β-cells during the pancreas development. Overall, Rb loss in islet progenitors led to increased islet precursors during islet development, with enhanced β-cell differentiation and postnatal β-cell proliferation and neogenesis. In contrast, α-cell development was compromised, along with increased apoptosis of α-cells, resulting in a persistently reduced α-to β-cell ratio. These changes in α-and β-cells together contributed to improved glucose homeostasis (Fig. 6E) . Deletion of Rb in mature β-cells results in mildly increased E2f2 expression, whereas cell proliferation and apoptosis are unaffected (22, 39) . However, Rb deletion combined with p130 mutation causes cells to further upregulate E2f2 expression, leading to increased β-cell proliferation. Interestingly, this was associated with p53-induced apoptosis, leading to a net loss of β-cell mass and hyperglycemia (39) . In contrast, we showed that deletion of Rb earlier in development in proliferating Pdx1-positive pancreatic progenitors led to an increase not only in E2f2 but also in E2f1 (Fig. 5E and Fig. S5F ), and this resulted in increased β-cell proliferation without a concomitant increase in β-cell apoptosis. These data suggest that E2f1 and E2f2 have distinct effects on p53 regulation, resulting in divergent outcomes in β-cell mass and function. E2f1 has also been shown to regulate transcription of Kir6.2, thereby affecting insulin secretion (25) . Here we observed enhanced β-cell function in p-RbKO mice, which is likely at least in part a result of increased Kir6.2. In addition to increased β-cells in p-RbKO, decreased α-cells likely also play a major role in improving glucose homeostasis. This may also explain the more profound phenotype observed in our p-RbKO mice compared with the insulin-driven Rb-deficient mice, which did not have α-cells disrupted (22) .
Postnatal Ngn3 expression has been linked with islet cell dedifferentiation (30); however, Ngn3 has also been described in adult human islets, mouse islets, and Min6 mouse insulinoma cells under normal conditions (40) . Interestingly, in these scenarios, Ngn3 was expressed primarily in the cytoplasm, rather than in the nuclei. During postnatal β-cell neogenesis, cytoplasmic Ngn3
+ cells differentiate into nuclear Ngn3 + cells and later coexpress insulin to finally become Ins + cells (41, 42) . This evidence indicates that the localization of Ngn3 may signify a specific state within the differentiation process of β-cells. Our p-RbKO mice showed an increased Ngn3 + precursor population and displayed an increase in both nuclear and cytoplasmic Ngn3 expression postnatally, which may indicate a neogenic process leading to increased differentiation into functional β-cells, as shown by Ngn3
+ cells coexpressing Glut2 and insulin. In α-cells, we show that loss of Rb resulted in accelerated apoptosis and cell cycle inhibition. After knockdown of Rb in α-TC cells, E2f1 levels increased dramatically, which was followed by a persistent increase in Arf; this led to an increase in p53. In contrast, Arf was decreased in Rb-deficient β-cells with a less dramatic rise of E2f1; this resulted in an overall decrease in p53 at least in part resulting from Mdm2-mediated degradation. These results illustrate the fine-tuning of multiple downstream effectors that are orchestrated by Rb in determining final cell fate.
In addition to postnatal cell proliferation, Rb has been shown to regulate cell lineage commitment (20) and the development of various tissues (43) . Here we illustrate a unique role of Rb in cell fate choice between pancreatic α-and β-cells. During pancreas development, the transcription factor Arx is detected at E9.5, which specifies α-cell lineage (28) . As such, Arx-deficient mice exhibit a complete absence of α-cells and proportionally increased β-and δ-cell number (44) . Interestingly, ectopic expression of Pax4 in Pdx1-or Pax6-expressing cells resulted in islet endocrine precursors and differentiated α-cells adopting a β-cell identity (29) . Accordingly, Arx suppression in our p-RbKO mice was associated with Pax4 induction, favoring differentiation of islet precursors to a β-cell identity. Our data indicate that E2f1 is a direct repressor of Arx gene expression and that E2f1 controls pancreatic α-and β-cell lineage commitment. E2f1 both activates and represses different genes and has similarly been found to repress the androgen receptor (45) and urokinase-type plasminogen activator (46) . In addition, E2f1 can autoregulate and activate itself when Rb is absent (47) . Together, these results suggest that Rb loss may induce E2f1, and activated E2f1s can furthermore directly repress Arx expression to decrease α-cell specification and cell mass.
Manipulation of Arx/Pax4 expression (28, 29) or β-cell ablation (31, 48) can force preexisting islet cells to reprogram into a new identity to compensate for α-or β-cell loss. However, this raises another issue: Can the reprogrammed cells function normally after adopting a new identity? Interestingly, reports show that β-cells reprogrammed from α-cells still have glucagon granules that coexist with insulin granules (31, 48) . Ectopic expression of Pax4 by a Pdx1 or Pax6 promoter led to β-cell expansion, but this only protected against diabetes in juvenile mice (<4 wk old), whereas older mice had worsened glucose tolerance (29) . Furthermore, islet cells from older mice did not undergo more proliferation (29, 31, 48) . These observations suggest that islet cells that undergo fate respecification perinatally may not provide long-term solutions for improving glucose tolerance. In contrast, our p-RbKO mice show an increase in postnatal β-cell neogenesis and display a skewing toward β-cell differentiation and α-to β-cell fate reprogramming during islet cell specification. Importantly, these favorable features were associated with an increase in cell proliferation that persisted into adulthood, leading to improved glucose tolerance and protection against diabetes.
In this study, we show that Rb is a critical determinant of pancreatic α-and β-cell fate through distinct mechanisms whereby Rb plays a dichotomous role in these two opposing endocrine cells. Rb loss in islet progenitors increases Ngn3-expressing precursors with enhanced β-cell differentiation and neogenesis. In contrast, Arx repression in Rb-deficient α-cells decreases differentiation and results in conversion to β-cells. Rb deficiency in both α-and β-cells leads to an induction of E2f1, but divergent regulation of p53 levels, which leads to further postnatal α-cell loss but expansion of functional β-cells, resulting in better glucose homeostasis and diabetes protection. Together, our study identifies the unique role of Rb in regulating pancreatic α-and β-cell fate, a potent mechanism for enhancing islet integrity and an innovative strategy for diabetes therapy.
Materials and Methods
Mouse Protocol and Cell Culture Experiments. Experimental procedures for glucose tolerance tests, insulin tolerance tests, glucose-stimulated insulin secretion, and multiple low-dose STZ-induced diabetes model were described previously (49) . Full methods are provided in SI Materials and Methods.
Staining and Molecular Studies. Experimental procedures for Ki67, insulin, and glucagon immunostaining and TUNEL assay were described previously (49) . Details of staining procedures, quantitative real-time PCR, Western blotting, and chromatin immunoprecipitation analyses are provided in SI Materials and Methods.
Statistical Analysis. Data are presented as mean ± SEs of the mean and were analyzed by two-tailed independent-sample Student t test or one-way ANOVA, as appropriate. P values < 0.05 were considered statistically significant. *P < 0.05; **P < 0.01; ***P < 0.001.
